Qualia NAD+
Asset
Nutritional formulation designed to enhance intracellular NAD+ levels and support cellular energy metabolism
- Stage
- Human trials
- Modality
- Supplement
- Target
- Oxidative phosphorylation
- 3
- Indications
- 3
- Trials
- 1
- Developer
Indications
3Intracellular nad+ levels
Human trials, Completed, NCT06812416, clinicaltrials.gov, 7 Oct 2026
NAD
Human trials, Completed, NCT07132801, clinicaltrials.gov, 7 Oct 2026
Nad+ levels in the blood
Human trials, Completed, NCT06505967, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials3
- Evidence for its targets3
- Competitors12
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 3 sources